Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)
NCT02876731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2016-08-24
Summary
Prospective, monocentric, comparative, non randomised
Primary objective :
\- to compare the diagnostic accuracy of sodium fluoride PET-CT and MRI using the conventional block and diffusion sequence in the search for bone metastases
Secondary objectives :
* compare accuracy of MRI diffusion and conventional MRI
* explore the evolution of the results of the different types of imaging over time or under treatment for patients with repeated examinations at 6 months
Conditions
- Cancer
- Bone Metastasis
Interventions
- DEVICE
-
PET-CT
NaF PET-CT
- DEVICE
-
MRI
DWMRI
Sponsors & Collaborators
-
Institut Jean-Godinot
lead OTHER
Principal Investigators
-
Yacine MERROUCHE · Institut Jean-Godinot
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
More Related Trials
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
NCT00882609 ·Status: UNKNOWN ·Phase: PHASE3
-
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
NCT00956163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
NCT04080271 ·Status: COMPLETED
-
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT
NCT05614518 ·Status: COMPLETED ·Phase: PHASE3
-
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
NCT06774729 ·Status: RECRUITING
-
MRI Perfusion on T1 and T2 Brain Lesion(s)
NCT02250755 ·Status: COMPLETED ·Phase: NA
-
FDG PET/CT in Breast Cancer Bone Mets
NCT01996046 ·Status: ACTIVE_NOT_RECRUITING
-
Management of Bone Metastases
NCT06713941 ·Status: ACTIVE_NOT_RECRUITING
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
NCT06659276 ·Status: RECRUITING
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma
NCT03382522 ·Status: COMPLETED
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
NCT06455722 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
NCT02839291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
NCT00414934 ·Status: UNKNOWN
-
Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases
NCT02636634 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)
NCT00503178 ·Status: COMPLETED ·Phase: PHASE2
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT06055764 ·Status: NOT_YET_RECRUITING